Difüzyon Ağırlıklı Manyetik Rezonans Görüntülemenin Benign ve Malign Adrenal Lezyonları Ayırt Etmedeki Değeri

Cilt: 38 Sayı: 4 1 Aralık 2013
Sevgül Kara Köse , F. Demir Apaydın , Kaan Esen , Anıl Özgür , Engin Kara , Sema Erden
PDF İndir
EN TR

Value of Diffusion Weighted Magnetic Resonance Imaging in Differentiation of Benign and Malignant Adrenal Lesions

Abstract

Objective: Diffusion weighted imaging (DWI) is a functional magnetic resonance imaging (MRI) technique that explores the random motion of water molecules in the body. Although DWI has been widely applied in the evaluation of intracranial disorders, there is growing interest for its use in detection and characterization of abdominal masses. In this study, the efficiency of DWI in distinguishing benign adrenal focal lesions from malignant ones is investigated. Material and Methods: Sixty six adrenal focal lesions in 56 patients were included in the study. The lesions were characterized with dynamic adrenal computed tomography and/or adrenal MRI if there was not a histopathological result or radiological follow up. DWI was performed for these lesions and apparent diffusion coefficient (ADC) values were measured by using three different b values (b=500 sec/mm2, b=750 sec/mm2, b=1000 sec/mm2). Results: The mean ADC values of 39 benign lesions were 1.54 x 10-3 mm2/sec for b=500 sec/mm2, 1.01x 10-3 mm2/sec for b=750 sec/mm2 and 0.77 x 10-3 mm2/sec for b=1000 sec/mm2. The mean ADC values of 27 malignant lesions were found to be 1.69x 10-3 mm2/sec, 1.14 x 10-3 mm2/sec and 0.86 x 10-3 mm2/sec for b=500 sec/mm2, b=750 sec/mm2, b=1000 sec/mm2, respectively. There was not any statistically significant difference between ADC values of benign and malignant lesions for all three b values (p

Keywords

Adrenal tumor, malign, benign, magnetic resonance imaging, diffusion weighted imaging

Kaynakça

  1. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology. 2003; 149:273-85.
  2. Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol. 2000; 163:398-407 .
  3. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996; 166:531-6.
  4. Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996; 167:861-7.
  5. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR. 1998; 171:201-4.
  6. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: Role in the management of neural crest tumors. Eur J Nucl Med. 1994; 21:561 T sushima Y, Takahashi-Taketomi A, Endo K. Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors. J Magn Reson Imaging. 2009; 29:112-7.
  7. Miller FH, Wang Y, McCarthy RJ, et al. Utilty of diffusion-weighted MRI in characterization of adrenal lesions. AJR. 2010; 194:179-85.
  8. Kılıçkesmez Ö, İnci E, Atilla S, et al. Diffusionweighted imaging of the renal and adrenal lesions. J Comput Assist Tomogr. 2009; 33:828-33.
  9. Elaine Caoili E M, Korbokin M, Francis I R, et al. Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT. Radiology. 2002; 222: 629-33.
  10. Yazıcı Z, Doğan Ö, Mehmet K, Savcı G. Value of chemıcal shıft mr ımagıng ın dıagnosıs of adrenal masses: quantitative analysis. Diagnostic and İnterventional Radiology. 2002; 8:377-83.

Kaynak Göster

MLA
Köse, Sevgül Kara, vd. “Difüzyon Ağırlıklı Manyetik Rezonans Görüntülemenin Benign ve Malign Adrenal Lezyonları Ayırt Etmedeki Değeri”. Cukurova Medical Journal, c. 38, sy 4, Aralık 2013, ss. 734-43, https://izlik.org/JA27EL44WW.